Orthopedic Trauma Devices MarketThe global orthopedic trauma devices market is expected to grow from an estimated USD 11.39 billion in 2024 to surpass USD 21.24 billion by 2034, registering a moderate ...

Combined Autologous Chondrocyte and Bone Marrow Mesenchymal Stromal Cell Implantation in the Knee: An 8-year Follow Up of Two First-In-Man Cases. Transendocardial CD34+ Cell Therapy does not ...

Panelists discuss how to optimize maintenance therapy following autologous stem cell transplantation by evaluating factors such as duration, drug selection, and risk-adapted approaches to maximize ...

Patients with biopsy-confirmed lightchain amyloidosis who underwent SCT between 8 March 1996 and 31 December 2011 were reviewed in two cohorts by date of transplantation: between 8 March 1996 and ...